Does BEVACIZUMAB Cause Hypomagnesaemia? 270 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 270 reports of Hypomagnesaemia have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.4% of all adverse event reports for BEVACIZUMAB.
270
Reports of Hypomagnesaemia with BEVACIZUMAB
0.4%
of all BEVACIZUMAB reports
42
Deaths
145
Hospitalizations
How Dangerous Is Hypomagnesaemia From BEVACIZUMAB?
Of the 270 reports, 42 (15.6%) resulted in death, 145 (53.7%) required hospitalization, and 16 (5.9%) were considered life-threatening.
Is Hypomagnesaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 270 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Hypomagnesaemia?
OMEPRAZOLE (1,766)
PANTOPRAZOLE (1,246)
PANITUMUMAB (611)
ESOMEPRAZOLE (591)
CARBOPLATIN (586)
LANSOPRAZOLE (504)
FUROSEMIDE (501)
FLUOROURACIL (477)
METFORMIN (415)
CISPLATIN (395)
Which BEVACIZUMAB Alternatives Have Lower Hypomagnesaemia Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ